(Q40105961)

17 September 2017

1 reference

title

Inhibitors of adenosine deaminase (English)

1 reference

adenosine deaminase inhibitors

17 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6187032

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

24 August 2023

author name string

R. P. Agarwal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6187032

24 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6187032

24 August 2023

publication date

1 January 1982

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0163725882900237?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

https://api.elsevier.com/content/article/PII:0163725882900237?httpAccept=text/plain

24 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Pharmacology & Therapeutics

24 August 2023

published in

1 reference

17 September 2017

17

1 reference

17 September 2017

3

1 reference

17 September 2017

399-429

1 reference

Enzyme inhibition in relation to chemotherapy

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin

24 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effects of adenosine analogs and adenine nucleotides on adenosine 5′-diphosphate-induced rat platelet aggregation

24 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine analogs and human platelets. Effects on nucleotide pools and the aggregation phenomenon

24 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells

24 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Deoxycoformycin toxicity in mice after long-term treatment

24 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency

24 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

A possible association between the nucleoside transport system of human erythrocytes and adenosine deaminase

24 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Potent inhibition of muscle 5′-AMP deaminase by the nucleoside antibiotics coformycin and deoxycoformycin

24 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine deaminase from human erythrocytes

24 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine deaminase from human erythrocytes: Purification and effects of adenosine analogs

24 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors

24 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Multiple forms of human adenosine deaminase. I. Purification and characterization of two molecular species

24 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

The control of the metabolism and the hormonal role of adenosine

24 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

On the mechanism of adenosine deaminase action

24 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Identification of the bioactive enantiomer of erythro-3-(adenin-9-yl)-2-nonanol (EHNA), a semi-tight binding inhibitor of adenosine deaminase

24 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Inhibition of maturation of human precursor lymphocytes by coformycin, and inhibitor of the enzyme adenosine deaminase

24 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro- and threo-9-(2-hydroxy-3-nonyl)adenines

24 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition

24 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine)

24 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

9-β-D-ARABINOFURANOSYLADENINE AS AN INHIBITOR OF METABOLISM IN NORMAL AND NEOPLASTIC CELLS

24 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

In Vitro Susceptibility of Varicella Zoster Virus to Adenine Arabinoside and Hypoxanthine Arabinoside

24 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor

24 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Studies of 6-N-hydroxylamino-9-beta-D-ribofuranosylpurine in mouse leukemia

24 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effect of adenosine deaminase inhibition upon human lymphocyte blastogenesis

24 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Inhibition by nitrobenzylthioinosine of uptake of adenosine, 2′-deoxyadenosine and 9-β-d-arabinofuranosyladenine by human and mouse erythrocytes

24 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Nitrobenzylthioinosine binding sites in the erythrocyte membrane

24 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Tight-binding inhibitors-I. Kinetic behavior

24 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.

24 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin

24 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzyme inhibition titration assay for 2′-deoxycoformycin and its application to the study of the relationship between drug concentration and tissue adenosine deaminase in dogs and rats

24 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Perfusion damage to renal allografts

24 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

The lethality of aranucleotides

24 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA)

24 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus

24 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine deaminase inhibitors: Differential effects on multiple forms of adenosine deaminase

24 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Hemolysis induced by 6-N-hydroxylaminopurine riboside, an adenosine analogue

24 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Elementary Steps in Enzyme Reactions (as Studied by Relaxation Spectrometry)

24 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Potential transition state analog for adenosine deaminase

24 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Antiviral Activity in the Rabbit Cornea of Adenine Arabinoside, Ara-A 5' Monophosphate, and Hypoxanthine Arabinoside; and Interactions with Adenosine Deaminase Inhibitor

24 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

A role for adenosine deaminase in human monocyte maturation

24 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

The Role of Adenosine and 2'-Deoxyadenosine in Mammalian Cells

24 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenylate deaminase: Potent inhibition by 2′-deoxycoformycin 5′-phosphate

24 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

24 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

The effects of 2′-deoxycoformycin on the action of cordycepin on nuclear RNA synthesis in regenerating liver

24 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Cordycepin and xylosyladenine: Inhibitors of methylation of nuclear RNA

24 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Evidence that xylosyladenine affects methylation by inhibition of S-adenosyl-L-methionine synthesis

24 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine metabolism in cultured lymphoid cells

24 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Letter: Preliminary data on the possible hypnogenic role of adenosine

24 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Specificity of adenosine deaminase inhibitors

24 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenine and Adenosine Are Toxic to Human Lymphoblast Mutants Defective in Purine Salvage Enzymes

24 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Conversion of human erythrocyte-adenosine deaminase activity to different tissue-specific isozymes. Evidence for a common catalytic unit

24 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency

24 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Role of adenosine deaminase in lymphocyte proliferation

24 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Two biochemical markers in lymphocyte subpopulations

24 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin

24 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Successful fetal liver transplantation in a child with severe combined immunodeficiency

24 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Inhibition of the phosphorylation of nonhistone chromosomal proteins by cordycepin and xylosyladenine in L1210 cells in vitro

24 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzymatic Catalysis and Transition-State Theory

24 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzymatic Catalysis and the Transition State Theory of Reaction Rates: Transition State Analogs

24 August 2023

89

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Inhibition of human T-cell rosette formation by the adenosine deaminase inhibitor erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA)

24 August 2023

90

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effect of an adenosine deaminase inhibitor on survival of mouse pancreatic islet allografts

24 August 2023

92

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Inhibition for Immunosuppression

24 August 2023

93

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Deoxycoformycin: neurological toxicity

24 August 2023

94

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies

24 August 2023

99

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Influence of Coformycin on the Cytostatic Activity of 9-β-D-Arabinofuranosyladenine and Adenosine in Mouse L5178y Cells

24 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

The molecular weight of adenosine deaminase in a number of species.

24 August 2023

102

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Structure of coformycin, an unusual nucleoside of microbial origin

24 August 2023

103

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Aranucleosides and aranucleotides in viral chemotherapy

24 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Partial purification and properties of the common inherited forms of adenosine deaminase from human erythrocytes

24 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Severe Combined Immunodeficiency and Adenosine Deaminase Deficiency

24 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

nucleoside-diphosphate kinases

24 August 2023

110

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs

24 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Inhibition of uridine uptake in HeLa cells by nitrobenzylthioinosine and related compounds

24 August 2023

112

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Potentiation by 2'-deoxycoformycin of the inhibitory effect of xylosyladenine on nuclear RNA synthesis in L1210 cells in vitro

24 August 2023

114

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effects of adenosine analogs on rat cerebral cortical neurons

24 August 2023

115

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo

24 August 2023

117

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency

24 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia

24 August 2023

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Tight binding inhibitors--VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and sarcoma 180 cells

24 August 2023

125

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Analysis by high-pressure liquid chromatography of 9-β-d-arabinofuranosyladenine 5′-triphosphate levels in murine leukemia cells

24 August 2023

127

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

In Vivo and in Vitro Effects of Thymosin and Adenosine Deaminase on Adenosine-Deaminase-Deficient Lymphocytes

24 August 2023

128

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Mode of inhibition of coformycin on adenosine deaminase

24 August 2023

130

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Formycin-deaminating activity of microorganisms

24 August 2023

131

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzyme inhibitors. 25. Equation to calculate the unknown Ki from two known values of Ki in an R,S, and RS series. Stereoselectivity of inhibition of adenosine deaminase by (R)-, (S)-, and (RS)-9-(1-hydroxy-2-alkyl and -aralkyl)adenines

24 August 2023

135

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines

24 August 2023

136

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzyme Inhibitors. XVIII. Studies on the Stereoselectivity of Inhibition of Adenosine Deaminase by DL-, D-, and L-9-(2-Hydroxypropyl)adenine

24 August 2023

137

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzyme Inhibitors. IX. Hydrophobic Interactions of Some 9-Alkyladenines with Adenosine Deaminase1,2

24 August 2023

138

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Enzyme Inhibitors. VIII. Studies on the Mode of Binding of Some 6-Substituted 9-(Hydroxyalkyl)purines to Adenosine Deaminase1,2

24 August 2023

139

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Antiviral Activity of Arabinosyladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells: Selective Inhibition of Viral Deoxyribonucleic Acid Synthesis in the Presence of an Adenosine Deaminase Inhibitor

24 August 2023

142

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Pathways of nucleotide metabolism in Schistosoma mansoni--VII. Inhibition of adenine and guanine nucleotide synthesis by purine analogs in intact worms

24 August 2023

143

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effect of 2′-deoxycoformycin on the biologic half-life of 9-β-d-arabinofuranosyladenine 5′-triphosphate in CHO cells

24 August 2023

145

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Synthesis of isocoformycin, an adenosine deaminase inhibitor of synthetic origin

24 August 2023

147

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo

24 August 2023

148

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Antiviral Activity of Arabinosyladenine and Arabinosylhypoxanthine in Herpes Simplex Virus-Infected KB Cells: Selective Inhibition of Viral Deoxyribonucleic Acid Synthesis in Synchronized Suspension Cultures

24 August 2023

149

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication

24 August 2023

151

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase

24 August 2023

152

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine deaminase activity in leukaemia

24 August 2023

154

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

In vivo toxicity to lymphoid tissue by 2'-deoxycoformycin

24 August 2023

155

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase

24 August 2023

159

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

The metabolism of 2'-deoxycoformycin by L1210 cells invitro

24 August 2023

163

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Adenosine Inhibition of Lymphocyte-Mediated Cytolysis: Possible Role of Cyclic Adenosine Monophosphate

24 August 2023

165

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Transition State Analogues for Enzyme Catalysis

24 August 2023

167

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Rate-determining step in the action of adenosine deaminase

24 August 2023

168

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Transition state analog inhibitors and enzyme catalysis

24 August 2023

170

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

Influence of substituent ribose on transition state affinity in reactions catalyzed by adenosine deaminase

24 August 2023

172

1 reference

https://api.crossref.org/works/10.1016/0163-7258(82)90023-7

24 August 2023

Identifiers

1 reference

17 September 2017

1 reference